980 related articles for article (PubMed ID: 26678807)
1. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.
Cani PD; Plovier H; Van Hul M; Geurts L; Delzenne NM; Druart C; Everard A
Nat Rev Endocrinol; 2016 Mar; 12(3):133-43. PubMed ID: 26678807
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
3. Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota.
Wisniewski PJ; Dowden RA; Campbell SC
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30626117
[TBL] [Abstract][Full Text] [Related]
4. Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases.
Russo R; Cristiano C; Avagliano C; De Caro C; La Rana G; Raso GM; Canani RB; Meli R; Calignano A
Curr Med Chem; 2018; 25(32):3930-3952. PubMed ID: 28215162
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids in the gastrointestinal tract.
Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
[TBL] [Abstract][Full Text] [Related]
6. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue.
Cani PD
Clin Microbiol Infect; 2012 Jul; 18 Suppl 4():50-3. PubMed ID: 22647050
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota, obesity and diabetes.
Patterson E; Ryan PM; Cryan JF; Dinan TG; Ross RP; Fitzgerald GF; Stanton C
Postgrad Med J; 2016 May; 92(1087):286-300. PubMed ID: 26912499
[TBL] [Abstract][Full Text] [Related]
9. Targeting the endocannabinoid system with microbial interventions to improve gut integrity.
Jansma J; Brinkman F; van Hemert S; El Aidy S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110169. PubMed ID: 33186639
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
Liu X; Cao S; Zhang X
J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
[TBL] [Abstract][Full Text] [Related]
11. A review of metabolic potential of human gut microbiome in human nutrition.
Yadav M; Verma MK; Chauhan NS
Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis.
De Filippo C; Costa A; Becagli MV; Monroy MM; Provensi G; Passani MB
Front Endocrinol (Lausanne); 2023; 14():1135157. PubMed ID: 37091842
[TBL] [Abstract][Full Text] [Related]
13. Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond.
Cani PD; Geurts L; Matamoros S; Plovier H; Duparc T
Diabetes Metab; 2014 Sep; 40(4):246-57. PubMed ID: 24631413
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid signalling regulates inflammation and energy balance: the importance of the brain-gut axis.
Cluny NL; Reimer RA; Sharkey KA
Brain Behav Immun; 2012 Jul; 26(5):691-8. PubMed ID: 22269477
[TBL] [Abstract][Full Text] [Related]
16. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract.
Lian J; Casari I; Falasca M
Pharmacol Res; 2022 Jan; 175():106025. PubMed ID: 34883211
[TBL] [Abstract][Full Text] [Related]
17. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
Swanson HI
Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis.
Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Guaza C
Biochem Pharmacol; 2018 Nov; 157():51-66. PubMed ID: 30171835
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine.
Smid SD
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1383-7. PubMed ID: 18671715
[TBL] [Abstract][Full Text] [Related]
20. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.
Storr MA; Yüce B; Andrews CN; Sharkey KA
Neurogastroenterol Motil; 2008 Aug; 20(8):857-68. PubMed ID: 18710476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
